Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation

References

• Ferenci P, Fried M, Labrecque D, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol. 2010;44(4):239–245. doi: 10.1097/MCG.0b013e3181d46ef2
   PubMed Web of Science ®Google Scholar
• Peng Z, Zhang Y, Gu W, et al. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol. 2005;26(2):467–473.
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang Z, Doo E, et al. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol. 1999;73(9):7231–7240.
   PubMed Web of Science ®Google Scholar
• Kim JH, Sohn SY, Benedict Yen TS, et al. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein. Biochem Biophys Res Commun. 2008;366(4):1036–1042. doi: 10.1016/j.bbrc.2007.12.070
   PubMed Web of Science ®Google Scholar
• Wang W, Cote J, Xue Y, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 1996;15(19):5370–5382. doi: 10.1002/j.1460-2075.1996.tb00921.x
   PubMed Web of Science ®Google Scholar
• Wang W, Xue Y, Zhou S, et al. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 1996;10(17):2117–2130. doi: 10.1101/gad.10.17.2117
   PubMed Web of Science ®Google Scholar
• Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res. 2009;69(21):8223–8230. doi: 10.1158/0008-5472.CAN-09-2166
   PubMed Web of Science ®Google Scholar
• Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. U.S.A.. 2004;101(3):811–816. doi: 10.1073/pnas.0304146101
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao Z, Meyer MB, et al. CARM1 Methylates chromatin remodeling factor BAF155 to Enhance tumor progression and Metastasis. Cancer Cell. 2016;30(1):179–180. doi: 10.1016/j.ccell.2016.06.013
   PubMed Web of Science ®Google Scholar
• Shadeo A, Chari R, Lonergan KM, et al. Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics. 2008;9:64. doi: 10.1186/1471-2164-9-64
   PubMed Web of Science ®Google Scholar
• Andersen CL, Christensen LL, Thorsen K, et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer. 2009;100(3):511–523. doi: 10.1038/sj.bjc.6604884
   PubMed Web of Science ®Google Scholar
• Aasland R, Stewart AF, Gibson T. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci. 1996;21(3):87–88.
   PubMed Web of Science ®Google Scholar
• Sohn DH, Lee KY, Lee C, et al. SRG3 interacts directly with the major components of the SWI/SNF chromatin remodeling complex and protects them from proteasomal degradation. J Biol Chem. 2007;282(14):10614–10624. doi: 10.1074/jbc.M610563200
   PubMed Web of Science ®Google Scholar
• Chen J, Archer TK. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol. 2005;25(20):9016–9027. doi: 10.1128/MCB.25.20.9016-9027.2005
   PubMed Web of Science ®Google Scholar
• Keppler BR, Archer TK. Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex. J Biol Chem. 2010;285(46):35665–35674. doi: 10.1074/jbc.M110.173997
   PubMed Web of Science ®Google Scholar
• Melegari M, Scaglioni PP, Wands JR. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol. 1998;72(3):1737–1743.
   PubMed Web of Science ®Google Scholar
• Huang J, Kwong J, Sun EC, et al. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol. 1996;70(8):5582–5591.
   PubMed Web of Science ®Google Scholar
• Chen WN, Liu LL, Jiao BY, et al. Hepatitis B virus X protein increases the IL-1beta-induced NF-kappaB activation via interaction with evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) [research support, Non-U.S. Gov't]. Virus Res. 2015;195:236–245. doi: 10.1016/j.virusres.2014.10.025
   PubMed Web of Science ®Google Scholar
• Ladner SK, Otto MJ, Barker CS, et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother. 1997;41(8):1715–1720. doi: 10.1128/AAC.41.8.1715
   PubMed Web of Science ®Google Scholar
• Li H, Zhuang Q, Wang Y, et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol. 2014;11(2):175–183. doi: 10.1038/cmi.2013.66
   PubMed Web of Science ®Google Scholar
• Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783–784. doi: 10.1038/nmeth.3047
   PubMed Web of Science ®Google Scholar
• Shalem O, Sanjana NE, Hartenian E, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (New York, NY). 2014;343(6166):84–87. doi: 10.1126/science.1247005
   Google Scholar
• Su ZJ, Cao JS, Wu YF, et al. Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity. Sci Rep. 2017;7:40246. doi: 10.1038/srep40246
   PubMed Web of Science ®Google Scholar
• Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. U.S.A.. 1987;84(4):1005–1009. doi: 10.1073/pnas.84.4.1005
   PubMed Web of Science ®Google Scholar
• Huang Q, Wang L, Bai S, et al. Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2. J Med Virol. 2009;81(9):1539–1550. doi: 10.1002/jmv.21593
   PubMed Web of Science ®Google Scholar
• Zhang Z, Torii N, Furusaka A, et al. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem. 2000;275(20):15157–15165. doi: 10.1074/jbc.M910378199
   PubMed Web of Science ®Google Scholar
• Feng H, Li X, Niu D, et al. Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis. J Proteomics. 2010 Jun 16;73(8):1421–1432. doi: 10.1016/j.jprot.2009.12.004
   PubMed Web of Science ®Google Scholar
• Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol. 2001;36(10):651–660. doi: 10.1007/s005350170027
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med. 2006;147(2):58–66. doi: 10.1016/j.lab.2005.10.003
   PubMed Web of Science ®Google Scholar
• Schek N, Bartenschlager R, Kuhn C, et al. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene. 1991;6(10):1735–1744.
   PubMed Web of Science ®Google Scholar
• Hartmann-Petersen R, Seeger M, Gordon C. Transferring substrates to the 26S proteasome. Trends Biochem Sci. 2003 Jan;28(1):26–31. doi: 10.1016/S0968-0004(02)00002-6
   PubMed Web of Science ®Google Scholar
• Orlowski M, Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch Biochem Biophys. 2003 Jul 1;415(1):1–5. doi: 10.1016/S0003-9861(03)00197-8
   PubMed Web of Science ®Google Scholar
• Xian L, Zhao J, Wang J, et al. P53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2. Mol Biol Rep. 2010;37(6):2935–2940. doi: 10.1007/s11033-009-9855-1
   PubMed Web of Science ®Google Scholar
• Xie Y, Castro-Hernandez R, Sokpor G, et al. RBM15 modulates the function of chromatin remodeling factor BAF155 through RNA methylation in developing cortex. 2019 Apr 24.
   Google Scholar
• Ali A, Abdel-Hafiz H, Suhail M, et al. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol. 2014;20(30):10238–10248. doi: 10.3748/wjg.v20.i30.10238
   PubMed Web of Science ®Google Scholar